Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Urges Biden Administration to Work Alongside…
The Biotechnology Innovation Organization (BIO) released the following statement in response to a bipartisan letter signed by 21 members of the U.S. House of Representatives. Led by Reps. Randy Feenstra (R-IA) and Dan Kildee (D-MI), the letter urged…
Learn more
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
Learn more
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Call for Sessions for BIO's Impact Ag & Environment Conference
April 27, 2023
BIO’s Impact Ag & Environment Conference, Sept. 19-20, 2023, in Raleigh, N.C., is an opportunity for companies and non-governmental organizations working across agriculture, bioprocessing, and climate adaptation/mitigation to connect and…
BIO to redouble efforts to ensure regulatory decision-making is "grounded in scientific and medical expertise"
April 21, 2023
The Supreme Court ruled today that mifepristone will remain accessible during the appeals process of the April 7 Texas ruling that would have declared the Food and Drug Administration (FDA) approval of the drug invalid.  BIO interim…
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS
April 11, 2023
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS “We will continue to organize and mobilize America’s scientific community to challenge this unprecedented effort to undermine…
New ruling out of Texas sets "dangerous precedent for undermining the FDA"
April 8, 2023
A federal judge in Texas rules this week to suspend the FDA’s approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement:  “The preliminary ruling by a federal judge in Texas is an assault on science…
Majority of American Voters Want Congress to Prioritize and Fund Public Health Preparedness, Poll Reveals
March 30, 2023
Healthcare Ready, Biotechnology Innovation Organization, and Wakefield Research release data  Washington (March 30, 2023) -- The last several years have shown that preparing for a public health emergency is vital to protect the public, our…
Innovation & Jobs Act Needed to Spur Innovation and Strengthen America's Global Competitiveness
March 17, 2023
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
BIO Welcomes John Delacourt as Deputy General Counsel
March 15, 2023
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…
Silicon Valley Bank and Biotech
March 13, 2023
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…
White House Budget Proposal a "Costly Blow" to Patients, Innovation
March 9, 2023
President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy…
Ag & Bioscience Groups: It's Time for Action on Mexico's Biotech Corn Ban
March 9, 2023
A broad coalition of national and state agriculture and bioscience organizations have written President Biden to thank the administration for beginning technical consultations with Mexico concerning its action to ban imports of biotech corn. The…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today